Manufacturer:

Janssen

Name:

DARZALEX

Category:

J Code

HCPCS:

J9145

NDC(s):

57894-0502-05, 57894-0502-20,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

DARZALEX is a Cancer drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9145 is aligned to the drug DARZALEX.